R&D Systems™ Recombinant Human IFN-alpha/beta R1 Fc Chimera Protein, CF

Catalog No.
11-574-AB050	50 μg

Catalog No. 11-574-AB050 Supplier R&D Systems™ Supplier No. 11574AB050

Description

Recombinant Protein

Measured by its binding ability in a functional ELISA. Recombinant Human IFN-alpha/beta R1 Fc Chimera (Catalog # 11574-AB) binds Recombinant Human LRPAP (Catalog # 4296-LR ) with an ED50 of 0.750-9.00 μg/mL.

Specifications

• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
• Gene ID (Entrez): 3454
• Molecular Weight (g/mol): MolecularWeight-observed: 105-120 kDa, under reducing conditions., MolecularWeight-theroretical: 74 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human IFN-alpha/beta R1 protein Human IFNAR1 (Lys28-Lys436) (N-terminus) Accession # AAA52730.1 GGIEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1 μg of the protein by the LAL method.
• Gene Alias: alpha-type antiviral protein, AVP, beta-type antiviral protein, CRF2-1, Cytokine receptor class-II member 1, Cytokine receptor family 2 member 1, human interferon-alpha receptor (HuIFN-alpha-Rec)10IFRC, IFN-alpha/beta receptor 1, IFN-alpha-REC, IFNAR, IFN-aR1, IFNAR1, IFNBR, IFNbR1, IFN-bR1, IFN-R-1, interferon (alpha, beta and omega) receptor 1, interferon alpha/beta receptor 1, interferon-alpha/beta receptor alpha chain, interferon-beta receptor 1, Type I interferon receptor 1
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 250 μg/mL in water.
• Protein: IFN-alpha/beta R1